Spinal Fusion for Congenital Scoliosis
Treatment for Congenital musculoskeletal and limb anomalies
Typical Dosage: Single surgical procedure
Effectiveness
85%
Safety Score
52%
Clinical Trials
100
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
52
DangerousModerateSafe
Treatment Details
Dosage Range
Single surgical procedure
Time to Effect
Immediate correction, functional recovery 6-12 months, full fusion 1-2 years
Treatment Duration
One-time surgery, long recovery
Evidence Quality
HIGHConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$5,000
Side Effect Mgmt:$2,000
Total Annual:$80,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POORICER
$180,000/QALY
QALYs Gained
1.5
Outcome-Based Costs
Cost per Responder
$94,117.65
Cost per Remission
$100,000
Spinal Fusion for Congenital Scoliosis Outcomes
for Congenital musculoskeletal and limb anomalies
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+85%
Remission Rate
+80%
Common Side Effects
Pain
+40%
Infection
+3%
Blood loss requiring transfusion
+10%
Neurological deficit (rare)
+1%
Pseudarthrosis (failure of fusion)
+5%
Hardware complications
+5%
Restricted spinal mobility
+100%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov